TrialJournal of inherited metabolic disease2018

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.

Line Borgwardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.